Meet Vektor Medical
Why is your company the best option to solve the problem you're solving?
Cardiac arrhythmias impact millions of people across the globe, increasing the risk of serious health-related issues, including stroke and even death. Yet, the current standard of care - including anti-arrhythmic drugs and blind, anatomical-based ablation therapy - is sub-optimal and is associated with severe side effects and disappointingly low success rates. Vektor Medical's patented, transformative technology is designed to inform clinical management of cardiac arrhythmias by providing physicians with actionable information to evaluate, locate, and potentially treat the patient's arrhythmia.
What nuggets of info make you interesting? Why do people care about what you're doing?
Vektor's technology is designed to be non-invasive, rapid, and optimized for the clinical workflow. The combination of these attributes represent an important and unique contribution to the arrhythmia care market.
What else do you want us to know?
Vektor Medical has developed a non-invasive arrhythmia mapping technology that uses advanced computational modeling and the patient's electrocardiogram (ECG) data. In a matter of minutes, Vektor's technology is able to provide 3-D information that the electrophysiologist can consider, evaluate, and potentially target.
BEHIND THE COMPANY
CEO/Founder: Mike Monko
What is your company's secret sauce?
As the technology is non-invasive, rapid, and designed for the clinical workflow, it is scalable and ripe for rapid market adoption.
What inspired you to start/run this company?
I've seen many innovative technologies and products over the years. This technology distinguished itself because it directly addresses a well-known but unmet need in cardiac care. The information provided by vMap is valuable and actionable for physicians evaluating treatment options. As soon as I understood the technology, I knew I had to do everything in my power to expedite this technology, get it out in the market, and help the millions suffering from cardiac arrhythmias around the globe.